Metabolite Biomarkers for Therapeutic Development and Monitoring in Multiple Myeloma Grant

Metabolite Biomarkers for Therapeutic Development and Monitoring in Multiple Myeloma .

date/time interval

  • April 20, 2022 - February 28, 2023

awarded by

administered by

sponsor award ID

  • Agreement 68492832

contributor